PATH | VRL
Menu

Find resources

Total results with these characteristics: 341

Resource type: Report

Page 17 of 18
Vesikari Clinical Severity Scoring System Manual

This manual provides a suggested standardized methodology for implementing the Vesikari Clinical Severity Scoring System across rotavirus vaccine studies and provides details on scoring system parameters, identifies implementation challenges, and …

Author: Kristen Lewis

Publication date: 2011

Victims of Our Own Success: Will Immunization Remain the Paradigm of Effective Prevention

This issue brief, based on a GIH roundtable discussion of select grantmakers and national experts in childhood immunization, explores various factors influencing public acceptance of childhood immunization; the importance of ensuring and conveying …

Author: Grantmakers in Health (GIH)

Publication date: 2001

Vietnam: Progress Beyond High Coverage

This report discusses the work of PATH's Children's Vaccine Program, in close collaboration with the Vietnamese National Expanded Program on Immunization, to increase immunization program quality, safety, and efficiency.

Author: PATH

Publication date: 2006

VIEW-hub – Vaccine Information and Epidemiology Window

This web page provides a link to the most recent VIEW-hub Report, as well as an archive of earlier reports. This quarterly report provides data and figures on the introduction status of Haemophilus influenzae type b, pneumococcal conjugate, …

Author: International Vaccine Access Center

Vigilancia Epidemiológica de Diarreas Causadas por Rotavirus

This Spanish-language document provides information on rotavirus disease and vaccines, including epidemiology and prevention and treatment of the disease.

Author: Pan American Health Organization

Publication date: 2007

White Paper – Rotavirus: Common, Severe, Devastating, Preventable

This white paper provides a comprehensive source of information on rotavirus disease and vaccines. The 50-page synthesis includes the latest evidence and programmatic information about: rotavirus disease burden; vaccines in global use, nationally …

Author: ROTA Council

Publication date: 2016

WHO Brighton Collaboration on Maternal Immunization Meeting Report

This report summarizes a consultation meeting held jointly by the World Health Organization's Initiative for Vaccine Research and the Brighton Collaboration in Geneva, Switzerland, from July 24 to 25, 2014 to facilitate harmonization of key events …

Author: World Health Organization

Publication date: 2014

WHO Global Action Plan to Minimize Poliovirus Facility-Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Polio Vaccine Use

This is the third edition of the Global Action Plan for eradicating polio. It includes suggested guidelines for the safe handling and containment of poliovirus infectious and potentially infectious materials, with the goal of reduced risk of …

Author: World Health Organization

Publication date: 2015

WHO Guidance Note: Vaccine Diluents, Revision 2015

This guidance note explains the proper handling and use of vaccine diluents, including critical steps for reconstituting vaccines safely and the appropriate storage and stock management procedures. This document is designed to be used in conjunction …

Author: World Health Organization

Publication date: 2015

WHO Policy Statement: Multi-dose Vial Policy (MDVP) - Handling of Multi-dose Vaccine Vials After Opening

This document is designed to provide guidance to national and senior-level program managers on the proper handling of multi-dose vaccine vials once opened. It presents the World Health Organization’s official position on this issue, including the …

Author: World Health Organization

Publication date: 2014

WHO Preferred Product Characteristics for Group B Streptococcus Vaccines

This report provides guidance on vaccine development strategies and targets for group B Streptococcus vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target …

Author: World Health Organization

Publication date: 2017

WHO Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines

This report provides guidance on vaccine development strategies and targets for RSV vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target population, …

Author: World Health Organization

Publication date: 2017

WHO Preferred Product Characteristics (PPC) for Malaria Vaccines

This document provides guidance for vaccine manufacturers and funding agencies in refining their product development plans for malaria vaccines. It clarifies the World Health Organization's preferences with regard to many criteria that form part of …

Author: World Health Organization

Publication date: 2014

WHO Recommendations for Routine Immunization: Summary Tables

These summary tables are designed to assist program managers in developing optimal immunization schedules using key information from the World Health Organization (WHO). The first table summarizes recommended routine immunizations for all age …

Author: World Health Organization

Publication date: 2017

WHO Strategy to Pilot Global Respiratory Syncytial Virus Surveillance Based on the Global Influenza Surveillance and Response System (GISRS)

This document presents the World Health Organization's (WHO's) strategy for leveraging the existing capacities of the Global Influenza Surveillance and Response System (GISRS) network for respiratory syncytial virus (RSV) surveillance without …

Author: World Health Organization

Publication date: 2017

WHO/Health Canada Drafting Group Meeting on Scientific and Regulatory Considerations on the Stability Evaluation of Vaccines Under Controlled Temperature Chain

On December 4 to 6, 2012, a consultation was held under the auspices of the World Health Organization (WHO) and Health Canada in Ottawa to identify obstacles to further developing a controlled temperature chain for vaccines. As described in this …

Author: World Health Organization

Publication date: 2013

WHO's Key Normative Processes and Institutions for Vaccines: A Primer

This policy brief describes three World Health Organization (WHO) normative institutions and processes pertaining to the issuance of technical guidelines and opinons about the public health value of new vaccines, their quality, and the …

Author: International AIDS Vaccine Institute

Publication date: 2008

Why Invest in Communication for Immunization? Evidence and Lessons Learned

This report identifies communication challenges that affect the success of immunization services; offers evidence of the contributions of communication activities; identifies lessons learned, and suggests ways in which communication can continue to …

Author: Waisbord S and Larson H

Publication date: 2005

World Malaria Report

This web page provides links to the annual World Malaria Report, which provides an up-to-date assessment of malaria-related policies adopted and applied in endemic countries, and contains the latest World Health Organization recommendations on …

Author: World Health Organization

Yaounde Declaration on Elimination of Meningococcal Meningitis Type A Epidemics as a Public Health Problem in Africa

This document outlines a pledge made by the ministers of health of African meningitis belt countries at the 58th session of the World Health Organization Regional Committee in Cameroon in 2008 to combat meningococcal disease in the region.

Author: World Health Organization

Publication date: 2008

Page 17 of 18